币界网报道：Stanford University researchers have developed a groundbreaking medical device called the Milli-Spinner, which has demonstrated a remarkable 95% reduction in blood clot formation during clinical trials. The compact, portable device utilizes a novel spinning mechanism to enhance blood circulation in immobilized patients, addressing a critical need in post-surgical and long-term care scenarios. Initial tests involving 2,506 patients across multiple hospitals showed significant improvements in preventing deep vein thrombosis (DVT) without requiring anticoagulant drugs, thereby eliminating associated bleeding risks. The Milli-Spinner's non-invasive design operates quietly for extended periods, making it suitable for both hospital and home use. Lead researcher Dr. Emily Zhang emphasized the device's potential to revolutionize preventive care, noting its cost-effectiveness compared to traditional pharmacological approaches. The team is now collaborating with medical manufacturers to expedite FDA approval and scale production, with an estimated market launch within 18 months. This innovation comes as global healthcare systems face increasing pressure to reduce hospital-acquired complications, with DVT affecting approximately 900,000 Americans annually according to CDC data. The Milli-Spinner's development was partially funded by the National Institutes of Health through its Biomedical Technology Advancement Initiative.